Information services provider Thomson Reuters, US, and Zynx Health, a subsidiary of Hearst Corporation, have announced that Thomson Reuters Micromedex will be integrated into ZynxOrder evidence-based order sets.
This integration pushes Micromedex clinical reference information to the point of care, giving physicians access to comprehensive drug information and disease protocols from their ZynxOrder evidence-based order set. Thomson Reuters will partner with Zynx Health as its source for order set solutions, and Zynx Health will offer Micromedex content as a preferred choice for clinical reference content. Joint customers will have contextual links from their ZynxOrder order sets into the Micromedex content.
This agreement unites Zynx Health's market leadership in providing evidence-based and experience-based clinical decision support solutions to more than 1,700 hospitals with Thomson Reuters' market leadership in providing Micromedex evidence-based clinical reference information to more than 3,500 hospitals. According to Thomas Hegelund, executive vice president at Thomson Reuters, the combination of ZynxOrder order sets and Micromedex evidence-based reference information integrated into the electronic health record and computerised physician order entry environment will give physicians comprehensive clinical information where they need it most.
Search for more Decision Support Tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
